AUDIT MicroControls, Inc. Announces Linearity FLQ Special Diabetes for Roche Systems

December 12, 2024 (Eatonton, GA) - AUDIT MicroControls, Inc. is pleased to announce the following new addition to our line of calibration verification/linearity and daily quality control products: Linearity FLQ Special Diabetes for Roche Systems. This product is intended to simulate human patient samples for use in determining linearity, calibration verification and verification of reportable range for the following analytes: C-peptide, Insulin, Fructosamine.